Pediatric aggressive mature b-cell lymphomas, version 2.2020

Kimberly Davies; Matthew Barth; Saro Armenian; Anthony N. Audino; Phillip Barnette; Branko Cuglievan; Hilda Ding; James B. Ford; Paul J. Galardy; Rebecca Gardner; Rabi Hanna; Robert Hayashi; Kovach E. Alexandra E.; Andrea Judit Machnitz; Kelly W. Maloney; Lianna Marks; Kristin Page; Anne F. Reilly; Joanna L. Weinstein; Ana C. Xavier; Nicole R. McMillian; Deborah A. Freedman-Cass

doi:10.6004/jnccn.2020.0036

Pediatric aggressive mature b-cell lymphomas, version 2.2020

Kimberly Davies, Matthew Barth, Saro Armenian, Anthony N. Audino, Phillip Barnette, Branko Cuglievan, Hilda Ding, James B. Ford, Paul J. Galardy, Rebecca Gardner, Rabi Hanna, Robert Hayashi, Kovach E. Alexandra E., Andrea Judit Machnitz, Kelly W. Maloney, Lianna Marks, Kristin Page, Anne F. Reilly, Joanna L. Weinstein, Ana C. XavierNicole R. McMillian, Deborah A. Freedman-Cass

Pediatrics

Research output: Contribution to journal › Review article › peer-review

6 Scopus citations

Abstract

Pediatric aggressive mature B-cell lymphomas are the most common types of non-Hodgkin lymphoma in children, and they include Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL). These diseases are highly aggressive but curable, the treatment is complex, and patients may have many complicated supportive care issues. The NCCNGuidelines for Pediatric Aggressive Mature B-Cell Lymphomas provide guidance regarding pathology and diagnosis, staging, initial treatment, disease reassessment, surveillance, therapy for relapsed/refractory disease, and supportive care for clinicians who treat sporadic pediatric BL and DLBCL.

Original language	English (US)
Pages (from-to)	1105-1123
Number of pages	19
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	18
Issue number	8
DOIs	https://doi.org/10.6004/jnccn.2020.0036
State	Published - Aug 2020

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2020.0036

Cite this

Davies, K., Barth, M., Armenian, S., Audino, A. N., Barnette, P., Cuglievan, B., Ding, H., Ford, J. B., Galardy, P. J., Gardner, R., Hanna, R., Hayashi, R., Alexandra E., K. E., Machnitz, A. J., Maloney, K. W., Marks, L., Page, K., Reilly, A. F., Weinstein, J. L., ... Freedman-Cass, D. A. (2020). Pediatric aggressive mature b-cell lymphomas, version 2.2020. JNCCN Journal of the National Comprehensive Cancer Network, 18(8), 1105-1123. https://doi.org/10.6004/jnccn.2020.0036

Davies, K, Barth, M, Armenian, S, Audino, AN, Barnette, P, Cuglievan, B, Ding, H, Ford, JB, Galardy, PJ, Gardner, R, Hanna, R, Hayashi, R, Alexandra E., KE, Machnitz, AJ, Maloney, KW, Marks, L, Page, K, Reilly, AF, Weinstein, JL, Xavier, AC, McMillian, NR & Freedman-Cass, DA 2020, 'Pediatric aggressive mature b-cell lymphomas, version 2.2020', JNCCN Journal of the National Comprehensive Cancer Network, vol. 18, no. 8, pp. 1105-1123. https://doi.org/10.6004/jnccn.2020.0036

@article{7f433a33368f4a7e8c05a79db3f4e578,

title = "Pediatric aggressive mature b-cell lymphomas, version 2.2020",

abstract = "Pediatric aggressive mature B-cell lymphomas are the most common types of non-Hodgkin lymphoma in children, and they include Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL). These diseases are highly aggressive but curable, the treatment is complex, and patients may have many complicated supportive care issues. The NCCNGuidelines for Pediatric Aggressive Mature B-Cell Lymphomas provide guidance regarding pathology and diagnosis, staging, initial treatment, disease reassessment, surveillance, therapy for relapsed/refractory disease, and supportive care for clinicians who treat sporadic pediatric BL and DLBCL.",

author = "Kimberly Davies and Matthew Barth and Saro Armenian and Audino, {Anthony N.} and Phillip Barnette and Branko Cuglievan and Hilda Ding and Ford, {James B.} and Galardy, {Paul J.} and Rebecca Gardner and Rabi Hanna and Robert Hayashi and {Alexandra E.}, {Kovach E.} and Machnitz, {Andrea Judit} and Maloney, {Kelly W.} and Lianna Marks and Kristin Page and Reilly, {Anne F.} and Weinstein, {Joanna L.} and Xavier, {Ana C.} and McMillian, {Nicole R.} and Freedman-Cass, {Deborah A.}",

note = "Publisher Copyright: {\textcopyright} National Comprehensive Cancer Network, Inc. 2020.",

year = "2020",

month = aug,

doi = "10.6004/jnccn.2020.0036",

language = "English (US)",

volume = "18",

pages = "1105--1123",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "8",

}

TY - JOUR

T1 - Pediatric aggressive mature b-cell lymphomas, version 2.2020

AU - Davies, Kimberly

AU - Barth, Matthew

AU - Armenian, Saro

AU - Audino, Anthony N.

AU - Barnette, Phillip

AU - Cuglievan, Branko

AU - Ding, Hilda

AU - Ford, James B.

AU - Galardy, Paul J.

AU - Gardner, Rebecca

AU - Hanna, Rabi

AU - Hayashi, Robert

AU - Alexandra E., Kovach E.

AU - Machnitz, Andrea Judit

AU - Maloney, Kelly W.

AU - Marks, Lianna

AU - Page, Kristin

AU - Reilly, Anne F.

AU - Weinstein, Joanna L.

AU - Xavier, Ana C.

AU - McMillian, Nicole R.

AU - Freedman-Cass, Deborah A.

PY - 2020/8

Y1 - 2020/8

N2 - Pediatric aggressive mature B-cell lymphomas are the most common types of non-Hodgkin lymphoma in children, and they include Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL). These diseases are highly aggressive but curable, the treatment is complex, and patients may have many complicated supportive care issues. The NCCNGuidelines for Pediatric Aggressive Mature B-Cell Lymphomas provide guidance regarding pathology and diagnosis, staging, initial treatment, disease reassessment, surveillance, therapy for relapsed/refractory disease, and supportive care for clinicians who treat sporadic pediatric BL and DLBCL.

AB - Pediatric aggressive mature B-cell lymphomas are the most common types of non-Hodgkin lymphoma in children, and they include Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL). These diseases are highly aggressive but curable, the treatment is complex, and patients may have many complicated supportive care issues. The NCCNGuidelines for Pediatric Aggressive Mature B-Cell Lymphomas provide guidance regarding pathology and diagnosis, staging, initial treatment, disease reassessment, surveillance, therapy for relapsed/refractory disease, and supportive care for clinicians who treat sporadic pediatric BL and DLBCL.

UR - http://www.scopus.com/inward/record.url?scp=85089171267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85089171267&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2020.0036

DO - 10.6004/jnccn.2020.0036

M3 - Review article

C2 - 32755986

AN - SCOPUS:85089171267

SN - 1540-1405

VL - 18

SP - 1105

EP - 1123

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 8

ER -

Pediatric aggressive mature b-cell lymphomas, version 2.2020

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this